STATINS AND MYOPATHY: MOLECULAR MECHANISMS

STATINS AND MYOPATHY: MOLECULAR MECHANISMS

Show other versions (1)

<p>The safety of statin therapy is considered. In particular the reasons of a complication such as myopathy are discussed in detail. The molecular mechanisms of statin myopathy , as well as its risk factors are presented. The role of coenzyme Q10 in the myopathy development and coenzyme Q10 ap...

Full description

Bibliographic Details
Main Authors: O. M. Drapkina, E. M. Chernova, O. N. Korneeva
Format: Article
Language:English
Published: Stolichnaya Izdatelskaya Kompaniya 2015-12-01
Series:Racionalʹnaâ Farmakoterapiâ v Kardiologii
Subjects:
статины
миопатия
коэнзим Q10
розувастатин
Online Access:http://www.rpcardio.ru/jour/article/view/472
id doaj-42ec33ef7e4b476ba4e1be1176209394
record_format Article
spelling doaj-42ec33ef7e4b476ba4e1be11762093942020-11-24T23:48:05ZengStolichnaya Izdatelskaya KompaniyaRacionalʹnaâ Farmakoterapiâ v Kardiologii1819-64462225-36532015-12-018346947310.1234/1819-6446-2012-3-469-473472STATINS AND MYOPATHY: MOLECULAR MECHANISMSO. M. Drapkina0E. M. Chernova1O. N. Korneeva2Первый Московский государственный медицинский университет им. И.М.СеченоваПервый Московский государственный медицинский университет им. И.М.СеченоваПервый Московский государственный медицинский университет им. И.М.Сеченова<p>The safety of statin therapy is considered. In particular the reasons of a complication such as myopathy are discussed in detail. The molecular mechanisms of statin myopathy , as well as its risk factors are presented. The role of coenzyme Q10 in the myopathy development and coenzyme Q10 application for the prevention of this complication are considered. </p>http://www.rpcardio.ru/jour/article/view/472статинымиопатиякоэнзим Q10розувастатин
collection DOAJ
language English
format Article
sources DOAJ
author O. M. Drapkina
E. M. Chernova
O. N. Korneeva
spellingShingle O. M. Drapkina
E. M. Chernova
O. N. Korneeva
STATINS AND MYOPATHY: MOLECULAR MECHANISMS
Racionalʹnaâ Farmakoterapiâ v Kardiologii
статины
миопатия
коэнзим Q10
розувастатин
author_facet O. M. Drapkina
E. M. Chernova
O. N. Korneeva
author_sort O. M. Drapkina
title STATINS AND MYOPATHY: MOLECULAR MECHANISMS
title_short STATINS AND MYOPATHY: MOLECULAR MECHANISMS
title_full STATINS AND MYOPATHY: MOLECULAR MECHANISMS
title_fullStr STATINS AND MYOPATHY: MOLECULAR MECHANISMS
title_full_unstemmed STATINS AND MYOPATHY: MOLECULAR MECHANISMS
title_sort statins and myopathy: molecular mechanisms
publisher Stolichnaya Izdatelskaya Kompaniya
series Racionalʹnaâ Farmakoterapiâ v Kardiologii
issn 1819-6446
2225-3653
publishDate 2015-12-01
description <p>The safety of statin therapy is considered. In particular the reasons of a complication such as myopathy are discussed in detail. The molecular mechanisms of statin myopathy , as well as its risk factors are presented. The role of coenzyme Q10 in the myopathy development and coenzyme Q10 application for the prevention of this complication are considered. </p>
topic статины
миопатия
коэнзим Q10
розувастатин
url http://www.rpcardio.ru/jour/article/view/472
work_keys_str_mv AT omdrapkina statinsandmyopathymolecularmechanisms
AT emchernova statinsandmyopathymolecularmechanisms
AT onkorneeva statinsandmyopathymolecularmechanisms
_version_ 1725487396130127872

Similar Items